Ipamorelin - Livewell Pharmaceuticals

Ipamorelin, a selective growth hormone secretagogue, mimics ghrelin by binding to GHSR-1a receptors in the pituitary and gastrointestinal tract. It enhances GH release, improves energy use, and influences adiposity. Clinical and animal studies show its potential to support gut recovery after surgery and induce early fat-weight gain without organ enlargement. In GH-deficient mice, ipamorelin raised body weight and fat mass without increasing liver size. Its mild side effect profile and targeted action suggest utility in metabolic dysfunction and hypogonadism-related therapy.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Ipamorelin by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.